Sign in

CIK 0001187953 · Non-accelerated filer<br>Smaller reporting company

CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC.

Sign in to watch
Ticker
CELZ
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
NV
Entity type
operating
EIN
870622284
Phone
480-399-2822
Business address
211 E. OSBORN RD., PHOENIX, AZ, 85012
Former names
JOLLEY MARKETING INC
  1. 4 Grant or award President & CEO acquired 1,000,000 shares (grant or award)
  2. 4 Open-market sale Director sold 1,500 shares at an average $5.38 ($8,063)
  3. 4 Open-market buy President & CEO bought 1,000 shares at an average $4.42 ($4,423)
  4. 4 Open-market buy President & CEO bought 25,000 shares at an average $0.39 ($9,862)
  5. 4 Open-market buy Director bought 2,000 shares at $0.50 ($1,000)
  6. 4 Open-market buy President & CEO bought 20,000 shares at $0.50 ($10,000)
  7. 4 Open-market buy President & CEO bought 42,000 shares at an average $0.59 ($24,817)
  8. 4 Open-market buy Director bought 10,000 shares at $0.70 ($7,000)
  9. 4 Open-market buy President & CEO bought 25,000 shares at an average $0.92 ($22,884)
  10. 4 Open-market buy Director bought 6,500 shares at $1.50 ($9,750)
  11. 4 Derivatives Options or other derivatives
  12. 4 Derivatives Options or other derivatives
  13. 3 Insider Initial Statement of Ownership
  14. 3 Insider Initial Statement of Ownership
  15. 3 Insider Initial Statement of Ownership
  16. 4 Open-market sale Director sold 4,350,000 shares at an average $0.03 ($132,405)
  17. 4 Derivatives Options or other derivatives
  18. 4 Derivatives Options or other derivatives
  19. 4 Derivatives Options or other derivatives
  20. 4 Option exercise Director acquired 10,000,000 shares (option exercise)

Page 1 of 4 · 70 filings